In certain groups of men, glucose-6-phosphate dehydrogenase (G6PD) deficiency was linked with an increased likelihood of severe COVID-19, a Veterans Affairs cohort study found. In Black men under 65, ...
A Denali Therapeutics drug for the rare enzyme deficiency Hunter syndrome is still in pivotal testing, but the company has guidance from the FDA on a pathway to get this therapy to the market sooner.
*Refers to the latest 2 years of stltoday.com stories. Cancel anytime. Dear Dr. Donohue - I would like to call your attention to a question you answered about emphysema. I think you should have ...
What Is Loargys, and Why Does It Matter? Loargys is an enzyme-based medicine that has been granted accelerated approval by the FDA for managing high levels of the amino acid arginine (hyperargininemia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results